Skip to main content

Advertisement

Table 6 Classification and economic impact of pharmaceutical interventions

From: Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan

Intervention type Number of cases of avoided ADRs Cost savings per case (USD) Cost savings (USD)
Avoidance of serious adverse drug reactions (ADRs) 56 21,400 1,198,400
Transvenous antimicrobial therapy interventionsa 265 1900 503,500
Interventions concerning cancer chemotherapy 210 1120 235,200
Avoidance of drug interactions
 High-risk drugs 8 840 6720
 Normal drugs 20 560 11,200
Renal dosing recommendations
 High-risk drugs 89 840 74,760
 Normal drugs 296 560 165,760
Avoiding intravenous drug incompatibility
 High-risk drugs 0 840 0
 Normal drugs 0 560 0
Confirmation of medication history
 High-risk drugs 21 840 17,640
 Normal drugs 39 560 21,840
Drug therapy consultation/recommendation (non-renal/extensive)
 High-risk drugs 160 840 134,400
 Normal drugs 515 560 288,400
Monitoring recommendation 80 0 0
Prescription term adjustment until next consultation day 0 0 0
Overall 1759   2,657,820
  1. aIncludes avoiding efficacy attenuation and improvement of prescription